These results, along with a preceding report exhibiting that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,two aid the principle of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-relevant Conditions. These final results propose that conolidine https://alvas048wpa3.nico-wiki.com/user